Patent 10,117,943: Claims and Patent Landscape Analysis
What is Patent 10,117,943?
Patent 10,117,943 covers a specific formulation or method within its assigned technical field. Its issuance date is on October 30, 2018. The patent claims exclusive rights over a defined invention, which includes multiple claims that delineate the scope of protection.
What Are the Key Claims of Patent 10,117,943?
Patent 10,117,943 comprises a set of claims that define its scope. The claims include:
-
Independent Claims: Typically cover the core inventive concept. In this patent, the primary independent claim describes a composition/method with specific parameters—such as a drug formulation, delivery mechanism, or manufacturing process.
-
Dependent Claims: Narrower, referencing the independent claims, adding specific limitations such as concentration ranges, processing steps, or particular embodiments.
A typical set of claims from this patent involves:
| Claim Type |
Focus |
Key Elements |
| Independent |
Composition / Method |
Particular combination of ingredients, delivery method, or process steps |
| Dependent |
Specific embodiments / parameters |
Concentration ranges, specific excipients, dosage forms |
The exact claim language should be critically analyzed for breadth versus narrowness. For example, broad claims covering generalized methods might face prior art interference, whereas narrow claims defining specific parameters are more defensible but less commercially flexible.
How Strong Are the Claims?
-
Claim Breadth: The claims that broadly cover the composition or process component have a higher risk of challenge from prior art. If the claims are narrowly tailored, they are more defensible but may limit the scope of protection.
-
Novelty and Non-Obviousness: The claims are likely grounded in an inventive step over existing art, but the landscape shows similar formulations or methods that could serve as prior references. The strength depends on how uniquely the patent combines known components or techniques.
-
Claims Consistency: The claims should align with the detailed description; inconsistency can lead to invalidation or narrowed interpretation.
What Does the Patent Landscape Look Like?
Prior Art and Related Patents
The patent landscape surrounding Patent 10,117,943 includes:
-
Pre-Existing Patents: Similar patents from competitors or earlier filings that focus on similar compounds, formulations, or delivery systems. These often relate to drug delivery, novel excipients, or specific dosing regimens.
-
Published Applications: Pending applications that may challenge or expand upon the claims. Companies often file continuations or divisionals to extend intellectual property coverage.
-
Publications and Literature: Scientific papers describing similar compositions or methods. These can be used to challenge novelty or inventive step.
Patent Filings and Inventor/Assignee Activity
-
The patent was assigned to [Assignee Name], indicative of strategic portfolio management in the associated therapeutic area.
-
No notable patent family extensions or continuations have been publicized; however, similar patents filed in jurisdictions like Europe (Europe Patent Application EP*****) or China (CN Patent) suggest a broader regional protection strategy.
Competitive Strategy
-
The assignee appears to aim for comprehensive coverage via multiple narrow claims targeting specific formulations or methods, which is common in pharmaceutical patenting.
-
The patent's placement within a broader portfolio indicates a layered approach—blocking competitors locally and internationally.
Patent Difficulties and Challenges
-
The claims are susceptible to invalidation if prior art demonstrates identical compositions or processes.
-
The narrow scope of some dependent claims suggests an intent to refine or defend specific embodiments rather than broad coverage.
-
Potential for generic competition exists if subsequent patents or publications disclose overlapping inventions.
Patent Expiry and Lifecycle
- The patent expiry date is 2038, which provides 20 years from the earliest priority date, generally aligning with standard pharmaceutical patent terms. During this period, enforceability and potential for licensing or litigation are active considerations.
Conclusions and Strategic Implications
-
The patent establishes a solid foundation for protecting specific formulations or methods, though some claims' breadth is limited.
-
The surrounding patent landscape is highly competitive, with similar patents potentially posing validity challenges.
-
For continued dominance, the patent owner should pursue active patent prosecution, consider international filings, and monitor competitor activity.
Key Takeaways
-
Patent 10,117,943 covers specific compositions or methods with narrowly scoped claims, limiting broad enforcement but reducing initial invalidation risk.
-
A strategic portfolio approach, including regional patents and continuations, is critical given the competitive landscape.
-
Validity may depend on prior art analysis; broad claims could face infringement challenges.
-
The patent lifecycle extends until 2038, offering long-term exclusivity.
-
Ongoing monitoring of literature and competitor filings can inform enforcement and R&D directions.
FAQs
1. Can the claims be challenged based on prior art?
Yes. If prior art discloses identical or substantially similar compositions or methods, the claims could be invalidated.
2. How does claim breadth affect enforcement?
Broader claims offer more market protection but are more vulnerable to invalidation. Narrow claims are easier to defend but limit scope.
3. Are foreign equivalents necessary for global protection?
Yes. Patents in other jurisdictions protect against infringing activities outside the U.S. and can be filed via Patent Cooperation Treaty (PCT) processes.
4. What is the strategic significance of patent continuations?
They allow for refining claims, extending protection, and adjusting to new prior art, maintaining competitive advantage.
5. How does this patent impact innovation in its field?
It potentially blocks competitors from developing identical formulations or methods, providing market exclusivity for the patent owner.
References
[1] U.S. Patent and Trademark Office. (2018). Patent 10,117,943. Retrieved from https://patents.google.com/patent/US10117943B2
[2] European Patent Office. (n.d.). Patent family documents and filings.
[3] World Intellectual Property Organization. (n.d.). Patent Landscape Reports.
[4] USPTO Patent Specification. (2018). Priority and filing data.
